Skip to main content
. 2019 Jun;65(6):416–425.

Figure 2.

Figure 2.

Proportion of TTR for A) the 13 481 patients taking warfarin (with an INR target range of 2.0 to 3.5) and B) the 5556 patients taking warfarin with known AF, DVT, or PE (with an INR target range of 2.0 to 3.0): Both were determined over the 2008 to 2016 study period.

AF—atrial fibrillation, DVT—deep vein thrombosis, INR—international normalized ratio, PE—pulmonary embolism, TTR—time in therapeutic range.